DNA Q2 2025 Earnings — Ginkgo Bioworks Holdings, Inc. Revenue & Financial Results | Market Cap Arena

DNAGinkgo Bioworks Holdings, Inc.

$418M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$50M-11.7% YoY

Gross Profit

$35M70.1% margin

Operating Income

-$66M-132.1% margin

Net Income

-$60M-121.6% margin

EPS (Diluted)

$-1.10

QoQ Revenue Growth

+2.7%

Cash Flow

Operating Cash Flow

-$40M

Free Cash Flow

-$40M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$618M

Stockholders' Equity

$613M

Cash & Equivalents

$204M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$50M	$56M	-11.7%
Gross Profit	$35M	$42M	-18.1%
Operating Income	-$66M	-$223M	+70.6%
Net Income	-$60M	-$217M	+72.2%

Revenue Segments

Service

$10M100%